Nanobody MET CAR-T cells show efficacy in solid tumors

Key Points

• Efficacy of VHH-CAR-T cells has been demonstrated in combatting solid tumors effectively.
• The quantifiable advantages include their small size and stability, leading to reduced tonic signaling.
• Analysis involves advanced CAR-T design focusing specifically on solid tumor treatment.
• Implications support the potential for using VHHs in future cancer therapies, warranting further exploration.

Abstract